• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
DNA flow cytometry of follicular non-Hodgkin's lymphoma.滤泡性非霍奇金淋巴瘤的DNA流式细胞术
J Clin Pathol. 1991 Mar;44(3):215-8. doi: 10.1136/jcp.44.3.215.
2
Flow cytometric analysis of DNA ploidy in large cleaved cell lymphomas.
Hematol Oncol. 1990 Nov-Dec;8(6):339-46. doi: 10.1002/hon.2900080606.
3
Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.流式细胞术检测的S期细胞分数作为非霍奇金淋巴瘤细胞学分级的补充生物学参数。
Diagn Cytopathol. 2003 Oct;29(4):194-9. doi: 10.1002/dc.10298.
4
Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
Haematologica. 1992 Jan-Feb;77(1):84-6.
5
Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.DNA流式细胞术在非霍奇金淋巴瘤中的预后重要性。
J Clin Pathol. 1986 May;39(5):542-6. doi: 10.1136/jcp.39.5.542.
6
DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry.恶性淋巴瘤的DNA倍体、增殖活性及免疫表型:流式细胞术的应用
Head Neck. 1998 Aug;20(5):392-8. doi: 10.1002/(sici)1097-0347(199808)20:5<392::aid-hed6>3.0.co;2-t.
7
Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
Cancer. 1990 Jun 1;65(11):2564-71. doi: 10.1002/1097-0142(19900601)65:11<2564::aid-cncr2820651128>3.0.co;2-p.
8
Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.通过DNA流式细胞术和Ki67评估弥漫性混合小细胞和大细胞非霍奇金淋巴瘤的生物学异质性。
Leuk Lymphoma. 1995 Nov;19(5-6):467-72. doi: 10.3109/10428199509112206.
9
Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).儿童非霍奇金淋巴瘤(NHL)和霍奇金病(HD)的倍性及增殖活性分析。
Pediatr Pathol Lab Med. 1997 Nov-Dec;17(6):893-902.
10
DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.犬非霍奇金淋巴瘤的DNA倍性和细胞动力学特征
Exp Hematol. 1993 Apr;21(4):579-84.

引用本文的文献

1
Clinical and molecular prognostic factors in follicular lymphoma.滤泡性淋巴瘤的临床和分子预后因素
Curr Oncol Rep. 2006 Sep;8(5):359-67. doi: 10.1007/s11912-006-0059-8.
2
Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.肿瘤细胞增殖而非凋亡可预测B细胞非霍奇金淋巴瘤的生存率。
Br J Cancer. 1998 Jun;77(11):1839-41. doi: 10.1038/bjc.1998.305.
3
Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.B细胞非霍奇金淋巴瘤中恶性及正常细胞的增殖与凋亡
Br J Cancer. 1998 Jun;77(11):1832-8. doi: 10.1038/bjc.1998.304.
4
Nucleolar organiser regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation.根据工作分类法分类的非霍奇金淋巴瘤患者的核仁组织区与生存情况
J Clin Pathol. 1993 Oct;46(10):943-7. doi: 10.1136/jcp.46.10.943.
5
Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.恶性非霍奇金淋巴瘤中凋亡指数与增殖指数的相关性
Am J Pathol. 1993 Mar;142(3):755-63.

本文引用的文献

1
Nodular mixed lymphocytic-histiocytic lymphoma (NM): response and survival. Eastern Cooperative Oncology Group.
Cancer. 1980 Jan 15;45(2):261-7. doi: 10.1002/1097-0142(19800115)45:2<261::aid-cncr2820450210>3.0.co;2-w.
2
Labeling index as a prognostic marker in non-Hodgkin's lymphomas.标记指数作为非霍奇金淋巴瘤的预后标志物
J Natl Cancer Inst. 1981 Jan;66(1):1-5.
3
Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience.
Int J Radiat Oncol Biol Phys. 1984 Apr;10(4):489-97. doi: 10.1016/0360-3016(84)90028-2.
4
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.使用流式细胞术分析石蜡包埋病理材料细胞DNA含量的方法。
J Histochem Cytochem. 1983 Nov;31(11):1333-5. doi: 10.1177/31.11.6619538.
5
Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II.
Cancer. 1983 Dec 15;52(12):2300-7. doi: 10.1002/1097-0142(19831215)52:12<2300::aid-cncr2820521224>3.0.co;2-y.
6
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.非霍奇金淋巴瘤基尔分类的临床及预后相关性:基尔淋巴瘤研究组前瞻性多中心研究结果
Hematol Oncol. 1984 Jul-Sep;2(3):269-306. doi: 10.1002/hon.2900020306.
7
The pattern of cell growth in reticulum cell sarcoma and lymphosarcoma.
Eur J Cancer (1965). 1970 Oct;6(5):453-63. doi: 10.1016/0014-2964(70)90045-9.
8
Comparison of DNA flow cytometry from fresh and paraffin embedded samples of non-Hodgkin's lymphoma.非霍奇金淋巴瘤新鲜样本与石蜡包埋样本的DNA流式细胞术比较。
J Clin Pathol. 1985 Oct;38(10):1096-9. doi: 10.1136/jcp.38.10.1096.
9
Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.非霍奇金淋巴瘤中的有丝分裂活性。与基尔分类及预后的关系。
Br J Cancer. 1987 Feb;55(2):219-23. doi: 10.1038/bjc.1987.41.
10
Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.
Cancer. 1986 Sep 15;58(6):1295-304. doi: 10.1002/1097-0142(19860915)58:6<1295::aid-cncr2820580620>3.0.co;2-h.

滤泡性非霍奇金淋巴瘤的DNA流式细胞术

DNA flow cytometry of follicular non-Hodgkin's lymphoma.

作者信息

Macartney J C, Camplejohn R S, Morris R, Hollowood K, Clarke D, Timothy A

机构信息

Department of Pathology, Alexandra Hospital.

出版信息

J Clin Pathol. 1991 Mar;44(3):215-8. doi: 10.1136/jcp.44.3.215.

DOI:10.1136/jcp.44.3.215
PMID:2013622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC496940/
Abstract

S-phase fraction, an index of cellular proliferation, and DNA ploidy were measured by DNA flow cytometry in a retrospective study of lymph node biopsy specimens from 83 cases (before treatment) of follicular non-Hodgkin's lymphoma, Working Formulation categories B and C. The correlations between these measures and survival, clinical stage, symptoms and histopathological factors were investigated. Aneuploidy was rare (n = 16) and had no effect on length of survival or transformation to high grade lymphoma. The overall mean S-phase fraction was 3.6%; for the whole series increasing S-phase fraction was associated with decreased survival. A high S-phase fraction (more than 5%) in initial biopsy specimens was also associated with an increased risk of subsequent high grade transformation at relapse. There was no difference between the survival or proliferative activity of tumours composed of mainly small cleaved cells compared with those composed of mixed small and large cells. There was no difference in survival or proliferative activity between tumours showing a pure follicular growth pattern and those with a mixed follicular and diffuse growth pattern. Multifactorial analysis showed that an S-phase fraction of more than 5% and B symptoms were the most important factors determining survival in these follicular non-Hodgkin's lymphomas.

摘要

在一项对83例(治疗前)工作分类为B和C级的滤泡性非霍奇金淋巴瘤患者淋巴结活检标本的回顾性研究中,通过DNA流式细胞术测量了细胞增殖指标S期分数和DNA倍性。研究了这些指标与生存、临床分期、症状及组织病理学因素之间的相关性。非整倍体罕见(n = 16),对生存时长或向高级别淋巴瘤转化无影响。总体平均S期分数为3.6%;在整个系列中,S期分数增加与生存时间缩短相关。初始活检标本中高S期分数(超过5%)也与复发时随后高级别转化风险增加相关。主要由小裂细胞组成的肿瘤与由小细胞和大细胞混合组成的肿瘤在生存或增殖活性方面无差异。呈现纯滤泡生长模式的肿瘤与具有滤泡和弥漫混合生长模式的肿瘤在生存或增殖活性方面无差异。多因素分析表明,S期分数超过5%和B症状是决定这些滤泡性非霍奇金淋巴瘤生存的最重要因素。